EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark Neo-X-Prime was filed as Word mark on 09/12/2022 at the European Union Intellectual Property Office.
It was registered as a trademark on 10/25/2023.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018760834 |
| Application date | September 12, 2022 |
| Publication date | October 14, 2022 |
| Entry date | October 25, 2023 |
| Expiration date | September 12, 2032 |
Trademark owner
Medicon Village, Scheelevagen 2
223 81 Lund
SE
223 81 Lund
SE
Trademark representatives
Riddargatan 10
114 35 Stockholm
SE
Objection / Complaint
goods and services
1
Antibodies [for scientific and immuno-oncological use]; libraries and collections of antibodies; antibody formats; bispecific antibody formats, therapeutic antibodies; bispecific antibody formats for immuno-oncological applications; bispecific compounds; none of the aforesaid goods being for use in newborn screening and invitro
5
Antibodies and libraries of antibodies for medical and pharmaceutical purposes; antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific antibody formats and bispecific compounds for medical and pharmaceutical purposes; antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific antibody formats and bispecific compounds for immuno-oncological applications; immuno-oncology preparations for medical and pharmaceutical purposes; antibodies; none of the aforesaid goods being for use in newborn screening and invitro
42
Bio-technology and scientific services relating to antibodies, antibody formats, bispecific antibody formats, therapeutic antibodies, and immune-oncology preparations; antibody evolving services; antibody library services; research, production and development services relating to antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific antibody formats and bispecific compounds; research, development and production of immuno-oncology antibody preparations and pharmaceuticals; information, advisory and consultancy services relating to all of the aforesaid services; none of the aforesaid goods being for use in newborn screening and invitro
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| February 16, 2023 | Change Representative, Registered |
ID: 11018760834